Cary Street Partners Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Cary Street Partners Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,140	Closed	-$225K	–	204
2024 Q1	$225K	Sell	4,140 -885	-18%	-$45.1K	0.03%	185
2023 Q4	$258K	Sell	5,025 -2,050	-29%	-$108K	0.04%	183
2023 Q3	$411K	Sell	7,075 -33,395	-83%	-$2.05M	0.08%	154
2023 Q2	$2.59M	Sell	40,470 -101	-0.2%	-$6.77K	0.48%	55
2023 Q1	$2.81M	Sell	40,571 -4,265	-10%	-$301K	0.53%	49
2022 Q4	$3.23M	Buy	44,836 +6,266	+16%	+$472K	0.65%	41
2022 Q3	$2.74M	Sell	38,570 -255	-0.7%	-$18.5K	0.66%	42
2022 Q2	$2.99M	Sell	38,825 -13,281	-25%	-$1.01M	0.7%	39
2022 Q1	$3.81M	Sell	52,106 -1,305	-2%	-$87.6K	0.76%	40
2021 Q4	$3.33M	Sell	53,411 -29,013	-35%	-$1.7M	0.71%	43
2021 Q3	$4.88M	Buy	82,424 +2,394	+3%	+$158K	1.72%	19
2021 Q2	$5.35M	Sell	80,030 -89,132	-53%	-$5.81M	1.28%	24
2021 Q1	$4.45M	Buy	169,162 +9,432	+6%	+$587K	1.09%	29
2020 Q4	$4.21M	Buy	+159,730	New	+$9.82M	1.24%	26

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cary Street Partners Asset Management's BMY Position: Q2 2024 in Review

Cary Street Partners Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 4,140 shares — an estimated $225K sold.

Cary Street Partners Asset Management first reported a position in BMY in Q4 2020 and held it in 14 quarters. The position peaked at $5.35M in Q2 2021. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Cary Street Partners Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Cary Street Partners Asset Management sold 4,140 Bristol-Myers Squibb shares in Q2 2024, an estimated $225K.
Cary Street Partners Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 14 quarters.
Cary Street Partners Asset Management's Bristol-Myers Squibb position peaked at $5.35M in Q2 2021.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2024, filed 22 Jul 2024.